Pradaxa News

Doyle Raizner Pradaxa Case Chosen for Bellwether Early Trial Consideration

By Press Release
August 1, 2013

As progress continues in the Pradaxa multi district litigation (MDL), the bellwether case selection process has concluded with one of Doyle Raizner’s cases being chosen.

Boehringer recalls one lot of Pradaxa

By Editorial Staff
From: Cardiovascular Business
November 14, 2012

Boehringer Ingelheim Pharmaceuticals has issued a voluntary recall of 75-mg dose dabigatran (Pradaxa), citing a potential packaging defect.

Boehringer recalls manufacturing lot of Pradaxa

By AP News
From: Business Week
November 7, 2012

NEW YORK (AP) — Boehringer Ingelheim said Wednesday it is recalling a single manufacturing lot of its anticlotting drug Pradaxa because the bottle may be defective.

Setback For Trial Studying Dabigatran After Mechanical Valve Surgery

By Larry Husten
October 23, 2012

Despite the recent advent of novel oral anticoagulants, the much-maligned warfarin remains the only current option available for patients who have received a mechanical valve.

Johnson & Johnson submits new data in 2nd shot at more approvals for anticlotting drug Xarelto

By Associated Press
From: Washington Post
September 7, 2012

TRENTON, N.J. — Johnson & Johnson said Friday that it has given the Food and Drug Administration additional data on its new anticlotting drug, in a second attempt to get approval for more uses.

Pradaxa MDL grows to 78 cases; Herndon wants litigation to ‘move expeditiously’

By Bethany Krajelis
From: The Record
August 31, 2012

Multi-district litigation over Pradaxa, a blood thinning medication, has grown to include 78 cases.

Personal Injury Attorney Doyle Raizner Supports Formation of Pradaxa MDL

By PR Web
From: PR Web
July 10, 2012

Doyle Raizner announces its support in the forming of a nationwide MDL, or multi-district litigation, formed to handle Pradaxa injury cases. With their experience they help people make the best decision about how and whether to proceed.

Doyle Raizner Law Firm to Help Pradaxa Victims

By PR Web
From: PR Web
July 7, 2012

Houston area law firm Doyle Raizner is reaching out to people who have taken Pradaxa, an anti-coagulant prescription drug that’s proving to have potentially fatal side effects. The firm, which frequently represents medical patients and the elderly in lawsuits involving unsafe drugs, decided to take action after the drug’s high fatality rate came to light earlier this month.

Studies Comparing Risk of Bleeding from Pradaxa vs. Warfarin Have Conflicting Results

By Tracy Ray
From: Injury Lawyer News
July 6, 2012

Two new studies that attempted to evaluate whether the risk of bleeding from Pradaxa is greater than that of Warfarin came up with conflicting results.

FDA Delays Decision on Pfizer, Bristol-Myers Drug

By Linda A. Johnson
From: The Kansas City Star
June 25, 2012
Page 1 of 212

Houston Main Office

  • map
  • 2402 Dunlavy St.
    Houston Texas
  • E-Mail Our Firm
    Phone: 713.571.1146
    Fax: 713.571.1148

Phoenix Office

  • map
  • 2929 E. Camelback Road, Suite 126
    Phoenix, AZ 85016
  • E-Mail Our Firm
    Fax: 480.685.5005

Galveston Office

  • map
  • 1894 Trube Estate Building
    2415 Market Street
    Galveston TX 77550
  • E-Mail Our Firm
    Phone: 409.740.6600
map  In the UK: 0871 218 1001